CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,106 | +45.4% | 114 | +18.8% | 0.00% | – |
Q2 2023 | $2,136 | -45.2% | 96 | -46.7% | 0.00% | – |
Q1 2023 | $3,899 | +99.9% | 180 | +87.5% | 0.00% | – |
Q4 2022 | $1,950 | -78.3% | 96 | -71.8% | 0.00% | -100.0% |
Q3 2022 | $9,000 | +350.0% | 340 | +254.2% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 96 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -50.0% | 96 | -50.5% | 0.00% | -100.0% |
Q4 2021 | $4,000 | +33.3% | 194 | +27.6% | 0.00% | 0.0% |
Q3 2021 | $3,000 | -57.1% | 152 | -51.6% | 0.00% | -50.0% |
Q2 2021 | $7,000 | +16.7% | 314 | +33.1% | 0.00% | +100.0% |
Q1 2021 | $6,000 | +20.0% | 236 | +33.3% | 0.00% | 0.0% |
Q4 2020 | $5,000 | +150.0% | 177 | +84.4% | 0.00% | 0.0% |
Q3 2020 | $2,000 | +100.0% | 96 | +92.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |